3 Stocks Estimated To Be Undervalued By Up To 36.9%

As the Dow and S&P 500 close at record highs, reflecting a strong start to 2026, investors are keenly observing the broader market dynamics shaped by recent economic indicators and policy developments. In this environment of heightened market performance, identifying undervalued stocks becomes crucial for those looking to capitalize on potential growth opportunities amidst these record-setting indices.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name Current Price Fair Value (Est) Discount (Est) VTEX (VTEX) $3.66 $7.12 48.6% Valley National Bancorp (VLY) $12.00 $23.24 48.4% Super Group (SGHC) (SGHC) $10.50 $20.96 49.9% Perfect (PERF) $1.73 $3.43 49.6% MGM Resorts International (MGM) $34.45 $67.98 49.3% Investar Holding (ISTR) $26.90 $53.60 49.8% Huntington Bancshares (HBAN) $18.24 $36.18 49.6% Fifth Third Bancorp (FITB) $49.27 $95.28 48.3% Datadog (DDOG) $125.49 $248.78 49.6% CNB Financial (CCNE) $26.23 $50.89 48.5%

Click here to see the full list of 192 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Let's explore several standout options from the results in the screener.

Caris Life Sciences

Overview: Caris Life Sciences, Inc. is an artificial intelligence TechBio company that offers molecular profiling services both in the United States and internationally, with a market cap of $8.04 billion.

Operations: The company's revenue primarily comes from its Biotechnology segment, generating $649.06 million.

Estimated Discount To Fair Value: 29.4%

Caris Life Sciences is trading at US$28.51, below its estimated fair value of US$40.36, suggesting it may be undervalued based on cash flows. Revenue grew by 68.3% over the past year, with expectations for continued growth surpassing the broader market rate. Recent strategic collaborations and index inclusions bolster its growth potential and financial outlook, while anticipated profitability within three years further enhances its appeal as an investment opportunity in precision oncology.

Insights from our recent growth report point to a promising forecast for Caris Life Sciences' business outlook. Navigate through the intricacies of Caris Life Sciences with our comprehensive financial health report here.CAI Discounted Cash Flow as at Jan 2026

AngloGold Ashanti

Overview: AngloGold Ashanti plc is a gold mining company with operations in Africa, Australia, and the Americas, and has a market cap of approximately $46.58 billion.

Operations: The company generates revenue primarily from its Metals & Mining segment, specifically Gold & Other Precious Metals, amounting to $8.58 billion.

Estimated Discount To Fair Value: 36.9%

Story Continues

AngloGold Ashanti is trading at US$92.25, significantly below its estimated fair value of US$146.31, indicating potential undervaluation based on cash flows. The company's earnings surged by a very large margin over the past year and are projected to grow significantly over the next three years, outpacing the broader US market. Despite an unstable dividend track record and recent insider selling, strong production results and robust earnings growth enhance its investment appeal in the mining sector.

Our expertly prepared growth report on AngloGold Ashanti implies its future financial outlook may be stronger than recent results. Click here and access our complete balance sheet health report to understand the dynamics of AngloGold Ashanti.AU Discounted Cash Flow as at Jan 2026

Coeur Mining

Overview: Coeur Mining, Inc. is a gold and silver producer operating in the United States, Canada, and Mexico with a market cap of $13.10 billion.

Operations: The company's revenue segments consist of Wharf at $294.12 million, Palmarejo at $420.20 million, Rochester at $377.30 million, Kensington at $322.30 million, and a Segment Adjustment of $286.80 million.

Estimated Discount To Fair Value: 32.1%

Coeur Mining is trading at US$20.4, below its estimated fair value of US$30.03, highlighting potential undervaluation based on cash flows. The company recently became profitable and its earnings are forecast to grow significantly over the next three years, surpassing overall market growth rates. Despite shareholder dilution in the past year, Coeur's extensive exploration program at Palmarejo promises resource expansion and mine life extension opportunities, reinforcing its investment potential within the mining industry.

Our earnings growth report unveils the potential for significant increases in Coeur Mining's future results. Get an in-depth perspective on Coeur Mining's balance sheet by reading our health report here.CDE Discounted Cash Flow as at Jan 2026

Seize The Opportunity

Reveal the 192 hidden gems among our Undervalued US Stocks Based On Cash Flows screener with a single click here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Searching for a Fresh Perspective?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CAIAU and CDE.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments